Transgene SA
PAR:TNG

Watchlist Manager
Transgene SA Logo
Transgene SA
PAR:TNG
Watchlist
Price: 1.105 EUR -8.3% Market Closed
Market Cap: 146.7m EUR

Wall Street
Price Targets

TNG Price Targets Summary
Transgene SA

Wall Street analysts forecast TNG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNG is 1.734 EUR with a low forecast of 1.414 EUR and a high forecast of 2.1 EUR.

Lowest
Price Target
1.414 EUR
28% Upside
Average
Price Target
1.734 EUR
57% Upside
Highest
Price Target
2.1 EUR
90% Upside
Transgene SA Competitors:
Price Targets
MDGL
Madrigal Pharmaceuticals Inc
9% Upside
CNTB
Connect Biopharma Holdings Ltd
230% Upside
TPST
Tempest Therapeutics Inc
10% Downside
TRDA
Entrada Therapeutics Inc
251% Upside
688520
Sinocelltech Group Ltd
12% Downside
SYRE
Spyre Therapeutics Inc
233% Upside
BCAX
Bicara Therapeutics Inc
184% Upside
GLUE
Monte Rosa Therapeutics Inc
238% Upside

Revenue
Forecast

Revenue Estimate
Transgene SA

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 4 years is 12%.

-3%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNG's stock price target?
Price Target
1.734 EUR

According to Wall Street analysts, the average 1-year price target for TNG is 1.734 EUR with a low forecast of 1.414 EUR and a high forecast of 2.1 EUR.

What is Transgene SA's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 4 years is 12%.

Back to Top